No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Express News | Mesoblast Ltd : Piper Sandler Raises to Overweight From Neutral; Raises Target Price to $11 From $4
Why Argosy Minerals, Flight Centre, Mesoblast, and Telix Shares Are Sinking Today
Mesoblast Raised to Overweight From Neutral by Piper Sandler
Mesoblast Price Target Raised to $11.00/Share From $4.00 by Piper Sandler
Mesoblast's Gets FDA Acceptance of Application for Allogeneic Cellular Therapy
Mesoblast Shares Rise on Start of Late-Stage Trial For Low Back Pain Treatment
No Data